BIIB

$215.43 2.62% $5.51
Sep 10, 2026 04:00 AM

Biogen specializes in the development of therapies for neurological diseases, including multiple sclerosis and Alzheimer’s.

Scroll or pinch to zoom · drag to pan the chart

Updating chart…

Price chart bar size:

Share on:

Asset Summary

Loading summary…

Asset Performance Metrics and Risk Characteristics:

Metrics below use daily returns for Jan 1, 2026 – Sep 10, 2026 (YTD).

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. Using indicators such as moving averages, pivot levels, momentum studies, and candlestick pattern scans can clarify trend strength and volatility. The tabs below summarize moving averages, pivots, technical indicators, candlestick patterns, and recent prices for this symbol.

Analysis

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Supercharge Your BIIB Trading Now

Discover unparalleled trading insights with OHLCX. Our automated system offers advanced analysis and technical indicators for BIIB, aimed at optimizing your trading decisions. Transform your trading strategy now and get ahead in the market now!

Start Optimizing Now

Frequently Asked Questions

Innovation is central to Biogen’s strategy, focusing on developing new therapies to address unmet medical needs in neurology.

Positive clinical trial results can lead to stock price increases and greater market confidence in Biogen’s products.

Biogen adheres to strict regulatory standards set by health authorities, conducting regular audits and reviews of its processes.

Yes, Biogen often collaborates with academic institutions and other companies for research and development purposes.

Biogen employs a rigorous approach, utilizing clinical trials and research to ensure safety and efficacy before launching new treatments.

Investors can track Biogen’s performance through financial news platforms, stock market apps, and Biogen’s investor relations page.

Recent developments include new clinical trial results and potential product launches; for the latest updates, check their press releases.

You can invest in Biogen by purchasing shares through a brokerage account or investing in funds that include Biogen in their portfolio.

Biogen faces challenges such as competition from other pharmaceutical companies and regulatory hurdles in drug approval processes.

Key products include Tecfidera, Avonex, and Spinraza, which are used for various neurological conditions.

Reveal Your BIIB Trading Now

Achieve superior trading results with OHLCX.com. Our platform provides expert analysis and actionable insights for BIIB, utilizing the latest technology to refine your investment approach. Boost your investment success with us now and see the impact on your trading success!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.